Somatostatinoma

• CLINICAL_TRIALS trial_result · 2022-10-19
  Clinical Trial Update: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors [Phase 2]

  Phase 2 trial evaluating temozolomide with or without capecitabine in advanced pancreatic neuroendocrine tumors, including subtypes such as …

• CLINICAL_TRIALS trial_result · 2021-12-15
  Clinical Trial Update: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors [Phase 2]

  Phase 2 trial evaluating regorafenib in advanced or metastatic neuroendocrine tumors has been completed with posted results.

• CLINICAL_TRIALS trial_result · 2021-09-22
  Clinical Trial Update: Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT [Phase 2]

  Phase 2 trial comparing Ga-DOTATOC PET sensitivity to Octreoscan SPECT+CT in medulloblastoma and related neuroendocrine tumors; results post…

• CLINICAL_TRIALS trial_result · 2020-12-30
  Clinical Trial Update: Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors [Phase 2]

  Phase 2 trial evaluating capecitabine, temozolomide, and bevacizumab for metastatic or unresectable pancreatic neuroendocrine tumors has com…

• CLINICAL_TRIALS withdrawal · 2017-07-19
  Clinical Trial Update: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors [Phase 2]

  Phase 2 trial of dovitinib lactate for pancreatic neuroendocrine tumors has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2013-06-04
  Clinical Trial Update: Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]

  Phase 2 clinical trial update evaluating gefitinib in patients with progressive/metastatic neuroendocrine tumors has completed. The study en…

• CLINICAL_TRIALS trial_result · 2013-06-04
  Clinical Trial Update: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]

  Phase 2 trial of romidepsin for locally advanced or metastatic neuroendocrine tumors was terminated; the document lists the conditions studi…